坦西罗莫司

Name: 坦西罗莫司
Brand: 济南圣和化工有限公司

CAS 162635-04-3C56H87NO16MW 1030.3

本页收录坦西罗莫司，CAS 登记号为 162635-04-3，分子式 C56H87NO16，分子量 1030.3，归类于有机化学品。作为主营产品之一，济南圣和化工有限公司可提供从公斤级到吨级的稳定供货，随货附 COA 与质检资料。

产品概览

CAS号	162635-04-3
分子式	C56H87NO16
分子量	1030.3
LogP	5.6
纯度	按批次COA提供(不公开发布)
包装	按订单/批次确认(不公开发布)
应用领域	有机化学品
类别	有机化学品

应用领域

有机化学品

坦西罗莫司主要应用于有机化学品。具体使用工况下的添加量与规格要求，欢迎与技术团队沟通确认。

包装与储存

包装规格按订单/批次确认(不公开发布)

纯度规格按批次COA提供(不公开发布)

储存条件密封、阴凉干燥处保存

运输常规化工运输

样品可协商提供

交期现货/按订单安排

采购提示：本产品按按订单/批次确认(不公开发布)起订发货，收到货物后请先核对包装完好性再行入库。储存条件为阴凉干燥、密封保存；如需 MSDS 或运输说明，可在询价时一并索取。

质量与文件

每批产品随货提供 COA（分析证书）；可按需提供 MSDS/技术数据表及第三方检测报告。纯度与包装以批次 COA 及订单确认为准。

关于供应商

济南圣和化工有限公司位于山东济南，主营化工原料供应，精选产品 2,000+ 种，覆盖有机化学品、无机化学品、食品添加剂、医药中间体等 12 大分类。我们随货提供 COA 分析证书，一个工作日内回复报价，欢迎国内外采购方长期合作。

常见问题

坦西罗莫司的 CAS 号是多少？

坦西罗莫司的 CAS 号为 162635-04-3。

该产品的纯度和包装规格是什么？

常规纯度规格为按批次COA提供(不公开发布)，包装为按订单/批次确认(不公开发布)，随货提供 COA。

坦西罗莫司有什么用途？

主要应用于有机化学品。

如何购买或获取报价？

请发送邮件至 info@591daili.com 或通过 WhatsApp 联系，注明产品名称、CAS 号与需求数量，一个工作日内回复报价。供应商：济南圣和化工有限公司。

PubChem 公开数据

Description

Temsirolimus · CAS 162635-04-3 · C56H87NO16. UNII 624KN6GM2T. Solubility: 2.35e-03 g/L.

Identification

CAS Registry Number	162635-04-3
PubChem CID	6918289
Molecular formula	C56H87NO16
UNII (FDA)	624KN6GM2T

Computed Descriptors

Molecular Weight	1030.3
XLogP3	5.6
Hydrogen Bond Donor Count	4
Hydrogen Bond Acceptor Count	16
Rotatable Bond Count	11
Exact Mass	1029.60248569
Monoisotopic Mass	1029.60248569
Topological Polar Surface Area	242
Heavy Atom Count	73
Formal Charge	0

Physical & Chemical Properties

Solubility	2.35e-03 g/L

Physical description & handling notes

Solid
White to off-white powder
White solid
Practically insoluble in water; soluble in alcohol
Solubility is independent of pH
Soluble in water

GHS Hazard Classification

Reported hazard statements	H360 (50.8%), H410 (95.1%)

H360 (50.8%): May damage fertility or the unborn child [Danger Reproductive toxicity]

H360FD (45.9%): May damage fertility; May damage the unborn child [Danger Reproductive toxicity]

Documented Uses

Preparation: J. S. Skotnicki et al., US 5362718 (1994 to Am. Home Prod.)
For the treatment of renal cell carcinoma (RCC). Also investigated for use/treatment in breast cancer, lymphoma (unspecified), rheumatoid arthritis, and multiple myeloma.
Temsirolimus is an inhibitor of cell proliferation and anticancer agent that is used as treatment of advanced renal cell cancer. Temsirolimus therapy is frequently associated with mild serum enzyme elevations, but has yet to be linked to instances of clinically apparent liver injury with jaundice.
Breast Feeding; Lactation; Immunosuppressive Agents
Antineoplastic Agents; Transplant Drugs
Temsirolimus is approved to treat:

Synonyms

Temsirolimus; CCI-779; 162635-04-3; Torisel; 624KN6GM2T; DTXSID2040945; DTXCID0020945; Rapamycin 42-(2,2-bis(hydroxymethyl)propionate); Rapamycin, 42-(3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate); temsirolimusum; L01XE09; Temsirolimus Injection; RefChem:56883; MFCD00934421; CHEMBL1201182; NCGC00167518-01

Frequently Asked Questions

What are the CAS number and molecular formula of Temsirolimus?

CAS 162635-04-3; molecular formula C56H87NO16; molecular weight — g/mol.

What other names is Temsirolimus known by?

Temsirolimus, CCI-779, 162635-04-3, Torisel, 624KN6GM2T, DTXSID2040945.

Is Temsirolimus classified as hazardous?

Hazard statements reported: H360, H410.

What are the key physical properties of Temsirolimus?

Solubility: 2.35e-03 g/L.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.